Skip to Main Content

Paper Details

An Antibody-Drug Conjugate Directed against Lymphocyte Antigen 6 Complex, Locus E (LY6E) Provides Robust Tumor Killing in a Wide Range of Solid Tumor Malignancies.
Clinical Cancer Research
29
2015
ADC, IFN, LY6E, LY6E protein, LY6E-expressing xenograft models, LY6E-specific ADC, LY6E-specific antibody, Locus E, Lymphocyte Antigen 6 Complex, Solid Tumor Malignancies, Tumor, anti-LY6E ADC, cancer, cells, human, lymphocyte antigen 6 complex locus E, monoclonal anti-LY6E antibody, neck carcinomas, patient, solid tumor, solid tumors, tumor

Datasets

Release 1.2